NOTICES 
21522 
RECOMBINANT DNA MOLECULE 
PROGRAM ADVISORY COMMITTEE 
Meeting 
Pursuant to Pub. L. 92-463, notice Is 
hereby given of the meeting of the Re- 
combinant DNA Molecule Program Ad- 
visory Committee on May 14-15, 1977, 
9 am, at the National Institutes of 
Health, Building 31C, Conference Room 
8, Bethesda, Maryland. This meeting 
will be open to the public on May 14, 
from 9 a.m. to 5 pm., and May 15, from 
9 a.m. to 3 pm. to discuss: guidelines for 
research involving recombinant DNA 
molecules, the status of research in the 
field, research studies required, the mech- 
anisms by which such studies should 
be supported, and the identification of 
facilities and resources needed in their 
performance. Attendance by the public 
will be limited to space available. 
In acpordance with the provisions set 
forth in sections 552b(c)(4), and 552b 
(c) (6), title 5, U.S. Code and section 10 
(d) of Pub. L. 92-463, the meeting will be 
closed to the public on May 15 from 3 
p.m. to 5 p.m. for the review, discussion 
and evaluation of initial pending and 
renewal grant applications. These appli- 
cations and the discussions could reveal 
confidential trade secrets or commercial 
property such as patentable material, 
and personal information concerning in- 
dividuals associated with the applica- 
tions. 
Dr. William J. Gartland, Executive 
Secretary, National Institutes of Health, 
Building 31, Room 4A52, Bethesda, Mary- 
land 20014, telephone 301-496-2323, will 
provide summaries of the meeting, ros- 
ters of committee members and substan- 
tive program information. 
Dated: April 18, 1977. 
Suzanne L. Fremeau, 
Committee Management Officer, 
National Institutes of Health. 
[PR Doc.77-12027 Filed 4-26-77:8:45 am] 
FEDERAL REGISTER, VOL. 42, NO. 81 — WEDNESDAY, APRIL 27, 1977 
[ 584 ] 
